Does NEMOLIZUMAB-ILTO Cause Neurodermatitis? 109 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 109 reports of Neurodermatitis have been filed in association with NEMOLIZUMAB-ILTO. This represents 2.6% of all adverse event reports for NEMOLIZUMAB-ILTO.
109
Reports of Neurodermatitis with NEMOLIZUMAB-ILTO
2.6%
of all NEMOLIZUMAB-ILTO reports
0
Deaths
2
Hospitalizations
How Dangerous Is Neurodermatitis From NEMOLIZUMAB-ILTO?
Of the 109 reports, 2 (1.8%) required hospitalization.
Is Neurodermatitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NEMOLIZUMAB-ILTO. However, 109 reports have been filed with the FAERS database.
What Other Side Effects Does NEMOLIZUMAB-ILTO Cause?
Inappropriate schedule of product administration (826)
Product dose omission issue (792)
Device malfunction (761)
Incorrect dose administered (579)
Pruritus (416)
Rash (263)
Headache (181)
Drug ineffective (158)
Device leakage (153)
Device use issue (120)
What Other Drugs Cause Neurodermatitis?
DUPILUMAB (1,577)
ADALIMUMAB (42)
SECUKINUMAB (29)
ETANERCEPT (24)
ATORVASTATIN (23)
OCRELIZUMAB (21)
TACROLIMUS (21)
ARIPIPRAZOLE (18)
METFORMIN (18)
VALSARTAN (17)
Which NEMOLIZUMAB-ILTO Alternatives Have Lower Neurodermatitis Risk?
NEMOLIZUMAB-ILTO vs NEOMYCIN
NEMOLIZUMAB-ILTO vs NEORAL
NEMOLIZUMAB-ILTO vs NEOSTIGMINE
NEMOLIZUMAB-ILTO vs NEOSTIGMINE METHYLSULFATE
NEMOLIZUMAB-ILTO vs NEPAFENAC